Integrating Single-Cell and Spatial Transcriptomics to Uncover and Elucidate GP73-Mediated Pro-Angiogenic Regulatory Networks in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) was characterized as being hypervascular. In the present study, we generated a single-cell spatial transcriptomic landscape of the vasculogenic etiology of HCC and illustrated overexpressed Golgi phosphoprotein 73 (GP73) HCC cells exerting cellular communication with vascular endothelial cells with high pro-angiogenesis potential via multiple receptor–ligand interactions in the process of tumor vascular development. Specifically, we uncovered an interactive GP73-mediated regulatory network coordinated with c-Myc, lactate, Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) pathway, and endoplasmic reticulum stress (ERS) signals in HCC cells and elucidated its pro-angiogenic roles in vitro and in vivo. Mechanistically, we found that GP73, the pivotal hub gene, was activated by histone lactylation and c-Myc, which stimulated the phosphorylation of downstream STAT3 by directly binding STAT3 and simultaneously enhancing glucose-regulated protein 78 (GRP78)-induced ERS. STAT3 potentiates GP73-mediated pro-angiogenic functions. Clinically, serum GP73 levels were positively correlated with HCC response to anti-angiogenic regimens and were essential for a prognostic nomogram showing good predictive performance for determining 6-month and 1-year survival in patients with HCC treated with anti-angiogenic therapy. Taken together, the aforementioned data characterized the pro-angiogenic roles and mechanisms of a GP73-mediated network and proved that GP73 is a crucial tumor angiogenesis niche gene with favorable anti-angiogenic potential in the treatment of HCC.

[1]  Ying Chai,et al.  In situ tissue profile of rat trigeminal nerve in trigeminal neuralgia using spatial transcriptome sequencing , 2024, International journal of surgery.

[2]  Q. Liao,et al.  Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential , 2023, Experimental & molecular medicine.

[3]  Li-li Zheng,et al.  Angiogenic signaling pathways and anti-angiogenic therapy for cancer , 2023, Signal transduction and targeted therapy.

[4]  Cong Yu,et al.  Integrated spatial transcriptome and metabolism study reveals metabolic heterogeneity in human injured brain , 2023, Cell reports. Medicine.

[5]  Lei Zhang,et al.  Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease , 2023, Frontiers in Immunology.

[6]  H. Tzeng,et al.  Tumor Vasculature as an Emerging Pharmacological Target to Promote Anti-Tumor Immunity , 2023, International journal of molecular sciences.

[7]  Xiaojing Ma,et al.  Aberrant expression of GOLM1 protects ALK+ anaplastic large cell lymphoma from apoptosis by enhancing BCL-XL stability , 2023, Blood Advances.

[8]  S. Ohnishi,et al.  Changes in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma , 2023, Cancers.

[9]  Lemin Zheng,et al.  Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies , 2023, Cancer biology & medicine.

[10]  A. Kater,et al.  JAK–STAT signalling shapes the NF‐κB response in CLL towards venetoclax sensitivity or resistance via Bcl‐XL , 2022, Molecular oncology.

[11]  Cheng Cao,et al.  GP73 blockade alleviates abnormal glucose homeostasis in diabetic mice. , 2022, Journal of Molecular Endocrinology.

[12]  Chenfei Wang,et al.  Evaluation of cell-cell interaction methods by integrating single-cell RNA sequencing data with spatial information , 2022, Genome Biology.

[13]  Maohui Luo,et al.  Integrative Analysis Reveals the Potential Role and Prognostic Value of GOLM1 in Hepatocellular Carcinoma , 2022, Oxidative medicine and cellular longevity.

[14]  Evan Z. Macosko,et al.  Cell type-specific inference of differential expression in spatial transcriptomics , 2022, Nature Methods.

[15]  L. Qin,et al.  Cholesterol suppresses GOLM1-dependent selective autophagy of RTKs in hepatocellular carcinoma. , 2022, Cell reports.

[16]  M. Ryten,et al.  ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2 , 2022, bioRxiv.

[17]  D. Hanahan Hallmarks of Cancer: New Dimensions. , 2022, Cancer discovery.

[18]  Hongchuan Jin,et al.  Golgi Phosphoprotein 73: The Driver of Epithelial-Mesenchymal Transition in Cancer , 2021, Frontiers in Oncology.

[19]  L. Qin,et al.  GOLM1 exacerbates CD8+ T cell suppression in hepatocellular carcinoma by promoting exosomal PD-L1 transport into tumor-associated macrophages , 2021, Signal Transduction and Targeted Therapy.

[20]  Qing Wang,et al.  GOLM1 Drives Colorectal Cancer Metastasis by Regulating Myeloid-derived Suppressor Cells , 2021, Journal of Cancer.

[21]  S. Zahler,et al.  Mechanical Aspects of Angiogenesis , 2021, Cancers.

[22]  Sohail M. Noman,et al.  Microbiomes and Resistomes in Biopsy Tissue and Intestinal Lavage Fluid of Colorectal Cancer , 2021, Frontiers in Cell and Developmental Biology.

[23]  C. Diaconu,et al.  Epigenetic Regulation of Angiogenesis in Development and Tumors Progression: Potential Implications for Cancer Treatment , 2021, Frontiers in Cell and Developmental Biology.

[24]  M. Safa,et al.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies , 2021, Journal of Hematology & Oncology.

[25]  Midie Xu,et al.  FBP1 regulates proliferation, metastasis, and chemoresistance by participating in C-MYC/STAT3 signaling axis in ovarian cancer , 2021, Oncogene.

[26]  Jinyun Dong,et al.  Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation. , 2021, Journal of medicinal chemistry.

[27]  Qian Zhang,et al.  C118P, a novel microtubule inhibitor with anti-angiogenic and vascular disrupting activities, exerts anti-tumor effects against hepatocellular carcinoma. , 2021, Biochemical pharmacology.

[28]  Z. Qiu,et al.  Long non-coding RNA TP73-AS1 promotes pancreatic cancer growth and metastasis through miRNA-128-3p/GOLM1 axis , 2021, World journal of gastroenterology.

[29]  Qifeng Yang,et al.  LINC01977 Promotes Breast Cancer Progression and Chemoresistance to Doxorubicin by Targeting miR-212-3p/GOLM1 Axis , 2021, Frontiers in Oncology.

[30]  Xianqun Fan,et al.  Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma , 2021, Genome biology.

[31]  Yuquan Wei,et al.  Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment , 2021, Cell proliferation.

[32]  E. Leung,et al.  The functional landscape of Golgi membrane protein 1 (GOLM1) phosphoproteome reveal GOLM1 regulating P53 that promotes malignancy , 2021, Cell death discovery.

[33]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[34]  D. Ribatti,et al.  Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma. , 2021, The American journal of pathology.

[35]  W. Qiu,et al.  Correction: Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5+ colorectal cancer , 2020, Cell Death and Disease.

[36]  Q. Ye,et al.  GOLM1 upregulates expression of PD-L1 through EGFR/STAT3 pathway in hepatocellular carcinoma. , 2020, American journal of cancer research.

[37]  Y. Wan,et al.  Golgi protein 73, hepatocellular carcinoma and other types of cancers , 2020, Liver research.

[38]  M. Papp,et al.  Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients , 2020, World journal of gastroenterology.

[39]  Yun-fei Yuan,et al.  Dysregulated Sp1/miR-130b-3p/HOXA5 axis contributes to tumor angiogenesis and progression of hepatocellular carcinoma , 2020, Theranostics.

[40]  Francisco Castillo,et al.  Structural and Biophysical Insights into the Function of the Intrinsically Disordered Myc Oncoprotein , 2020, Cells.

[41]  Jhin Jieh Lim,et al.  JAK/STAT signaling in hepatocellular carcinoma , 2020, Hepatic oncology.

[42]  Wenjie Zheng,et al.  Dynamic expression of hepatic GP73 mRNA and protein and circulating GP73 during hepatocytes malignant transformation. , 2020, Hepatobiliary & pancreatic diseases international : HBPD INT.

[43]  Zhi Chen,et al.  c-Myc transactivates GP73 and promotes metastasis of hepatocellular carcinoma cells through GP73-mediated MMP-7 trafficking in a mildly hypoxic microenvironment , 2019, Oncogenesis.

[44]  B. Ren,et al.  Metabolic regulation of gene expression by histone lactylation , 2019, Nature.

[45]  C. Yen,et al.  CPAP promotes angiogenesis and metastasis by enhancing STAT3 activity , 2019, Cell Death & Differentiation.

[46]  P. Bose,et al.  Advances in early diagnosis of hepatocellular carcinoma , 2019, Hepatoma Research.

[47]  Yanhong Zhang,et al.  Tumor Microenvironment Regulation by the Endoplasmic Reticulum Stress Transmission Mediator Golgi Protein 73 in Mice , 2019, Hepatology.

[48]  Yi Lv,et al.  Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma , 2019, Journal of Translational Medicine.

[49]  Xiaohui Ye,et al.  A meta-analysis of the prognostic significance of Golgi protein 73 in hepatocellular carcinoma in Chinese patients , 2019, Archives of medical science : AMS.

[50]  M. Zheng,et al.  CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer , 2019, Cell Death & Disease.

[51]  Yu Chen,et al.  Clinicopathological significance of miR-27b targeting Golgi protein 73 in patients with hepatocellular carcinoma , 2019, Anti-cancer drugs.

[52]  Paul J. Hoffman,et al.  Comprehensive Integration of Single-Cell Data , 2018, Cell.

[53]  Robert J. Griffin,et al.  Consensus guidelines for the use and interpretation of angiogenesis assays , 2018, Angiogenesis.

[54]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[55]  Hui-ni Wu,et al.  GP73 level determines chemotherapeutic resistance in human hepatocellular carcinoma cells , 2018, Journal of Cancer.

[56]  Honggang Zhou,et al.  Hsp90β promoted endothelial cell-dependent tumor angiogenesis in hepatocellular carcinoma , 2017, Molecular Cancer.

[57]  X. Wang,et al.  GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis. , 2016, Cancer cell.

[58]  Hong Zhang,et al.  mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice. , 2015, Gastroenterology.

[59]  B. Zhu,et al.  CXCL10 Decreases GP73 Expression in Hepatoma Cells at the Early Stage of Hepatitis C Virus (HCV) Infection , 2013, International journal of molecular sciences.

[60]  D. Hanahan,et al.  Modes of resistance to anti-angiogenic therapy , 2008, Nature Reviews Cancer.

[61]  Zhong Chen,et al.  STAT3: A critical transcription activator in angiogenesis , 2008, Medicinal research reviews.

[62]  D. Ribatti,et al.  The role of microenvironment in tumor angiogenesis , 2008, Genes & Nutrition.

[63]  A. Linstedt,et al.  Endosomal Trafficking and Proprotein Convertase Cleavage of cis Golgi Protein GP73 Produces Marker for Hepatocellular Carcinoma , 2007, Traffic.